Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016:951:123-135.
doi: 10.1007/978-3-319-45457-3_10.

Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions

Marcela K Preininger  1   2 , Monalisa Singh  1 , Chunhui Xu  3   4
Affiliations
Review

Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions

Marcela K Preininger et al. Adv Exp Med Biol. 2016.

Abstract

In recent years, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have emerged as a vital cell source for in vitro modeling of genetic cardiovascular disorders, drug screening, and in vivo cardiac regeneration research. Looking forward, the ability to efficiently cryopreserve hPSC-CMs without compromising their normal biochemical and physiologic functions will dramatically facilitate their various biomedical applications. Although working protocols for freezing, storing, and thawing hPSC-CMs have been established, the question remains as to whether they are optimal. In this chapter, we discuss our current understanding of cryopreservation appertaining to hPSC-CMs, and proffer key questions regarding the mechanical, contractile, and regenerative properties of cryopreserved hPSC-CMs.

Keywords: Beating; Cell viability; Contraction; Cryopreservation; Electrical coupling; Engraftment; Freezing; Human pluripotent stem cell-derived cardiomyocytes; Thawing; Transplantation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
General procedure for the cryopreservation of hPSC-CMs
Figure 2
Figure 2
General procedure for thawing cryopreserved hPSC-CMs
See this image and copyright information in PMC

References

    1. Turnbull IC, Lieu DK, Li RA, Costa KD. Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery. Drug Discov Today Dis Models. 2012;9(4):e219–e227. - PMC - PubMed
    1. Feric NT, Radisic M. Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues. Adv Drug Deliv Rev. 2016:96110–96134. - PMC - PubMed
    1. Birket Matthew J, Casini S, Kosmidis G, Elliott David A, Gerencser Akos A, Baartscheer A, Schumacher C, Mastroberardino Pier G, Elefanty Andrew G, Stanley EdG, Mummery Christine L. PGC-1α and reactive oxygen species regulate human embryonic stem cell-derived cardiomyocyte function. Stem Cell Reports. 2013;1(6):560–574. - PMC - PubMed
    1. Birket MJ, Ribeiro MC, Verkerk AO, Ward D, Leitoguinho AR, den Hartogh SC, Orlova VV, Devalla HD, Schwach V, Bellin M, Passier R, Mummery CL. Expansion and patterning of cardiovascular progenitors derived from human pluripotent stem cells. Nat Biotech. 2015;33(9):970–979. - PubMed
    1. Lui KO, Stachel MW, Lieu DK, Li RA, Bu L. Induced pluripotent stem cells as a disease model for studying inherited arrhythmias: promises and hurdles. Drug Discov Today Dis Models. 2012;9(4):e199–e207.

Publication types

MeSH terms